Anti–PD-L1 Plus Targeted Therapy in Anaplastic Thyroid Carcinoma
24 Oct 2024
• 20 min
• EN
Interview with Maria E. Cabanillas, MD, author of Anti–Programmed Death Ligand 1 Plus Targeted Therapy in Anaplastic Thyroid Carcinoma: A Nonrandomized Clinical Trial. Hosted by Vivek Subbiah, MD. Related Content: Anti–Programmed Death Ligand 1 Plus Targeted Therapy in Anaplastic Thyroid Carcinoma
From "JAMA Oncology Author Interviews"
Listen on your iPhone
Download our iOS app and listen to interviews anywhere. Enjoy all of the listener functions in one slick package. Why not give it a try?
Comments
Add comment Feedback